Hubei Guangji Pharmaceutical Co., Ltd. (000952.SZ)
CNY 5.32
(0.19%)
CNY 5.32
(0.19%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 187.93 Million CNY | -31.48% |
| 2022 | 295.11 Million CNY | -2.04% |
| 2021 | 301.24 Million CNY | 7.73% |
| 2020 | 279.63 Million CNY | -17.71% |
| 2019 | 339.79 Million CNY | -29.13% |
| 2018 | 479.47 Million CNY | 17.54% |
| 2017 | 407.94 Million CNY | 9.37% |
| 2016 | 373 Million CNY | 106.02% |
| 2015 | 181.05 Million CNY | 299.41% |
| 2014 | 45.33 Million CNY | -24.3% |
| 2013 | 59.87 Million CNY | 340.48% |
| 2012 | 13.59 Million CNY | -85.52% |
| 2011 | 93.89 Million CNY | -0.87% |
| 2010 | 94.71 Million CNY | 0.39% |
| 2009 | 94.34 Million CNY | -59.09% |
| 2008 | 230.6 Million CNY | -49.54% |
| 2007 | 456.99 Million CNY | 289.99% |
| 2006 | 117.18 Million CNY | 37.93% |
| 2005 | 84.95 Million CNY | 25.8% |
| 2004 | 67.53 Million CNY | -7.85% |
| 2003 | 73.28 Million CNY | -2.11% |
| 2002 | 74.86 Million CNY | -7.15% |
| 2001 | 80.62 Million CNY | 23.3% |
| 2000 | 65.39 Million CNY | -16.57% |
| 1999 | 78.38 Million CNY | 8.87% |
| 1998 | 71.99 Million CNY | 2.61% |
| 1997 | 70.15 Million CNY | 51.47% |
| 1996 | 46.31 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 28.55 Million CNY | -28.84% |
| 2024 Q1 | 29.49 Million CNY | -42.8% |
| 2024 Q2 | 44.88 Million CNY | 52.19% |
| 2023 Q3 | 44.69 Million CNY | -47.34% |
| 2023 Q4 | 51.56 Million CNY | 15.38% |
| 2023 Q1 | 21.07 Million CNY | -80.67% |
| 2023 FY | 202.19 Million CNY | -31.48% |
| 2023 Q2 | 84.86 Million CNY | 302.58% |
| 2022 FY | 295.11 Million CNY | -2.04% |
| 2022 Q4 | 109.02 Million CNY | 76.48% |
| 2022 Q1 | 42.99 Million CNY | -59.14% |
| 2022 Q2 | 81.31 Million CNY | 89.11% |
| 2022 Q3 | 61.77 Million CNY | -24.02% |
| 2021 FY | 301.24 Million CNY | 7.73% |
| 2021 Q1 | 58.85 Million CNY | -13.33% |
| 2021 Q2 | 62.87 Million CNY | 6.84% |
| 2021 Q3 | 74.27 Million CNY | 18.13% |
| 2021 Q4 | 105.23 Million CNY | 41.68% |
| 2020 FY | 279.63 Million CNY | -17.71% |
| 2020 Q4 | 67.9 Million CNY | -20.09% |
| 2020 Q2 | 88.4 Million CNY | 130.49% |
| 2020 Q3 | 84.97 Million CNY | -3.88% |
| 2020 Q1 | 38.35 Million CNY | -34.53% |
| 2019 Q1 | 88.97 Million CNY | -30.97% |
| 2019 Q3 | 92.41 Million CNY | -7.41% |
| 2019 Q4 | 58.57 Million CNY | -36.62% |
| 2019 FY | 339.79 Million CNY | -29.13% |
| 2019 Q2 | 99.81 Million CNY | 12.19% |
| 2018 Q1 | 169.53 Million CNY | 25.79% |
| 2018 FY | 479.47 Million CNY | 17.54% |
| 2018 Q4 | 128.89 Million CNY | 42.68% |
| 2018 Q3 | 90.34 Million CNY | -0.4% |
| 2018 Q2 | 90.7 Million CNY | -46.5% |
| 2017 Q4 | 134.76 Million CNY | 39.01% |
| 2017 FY | 407.94 Million CNY | 9.37% |
| 2017 Q1 | 82.43 Million CNY | -23.11% |
| 2017 Q2 | 93.78 Million CNY | 13.76% |
| 2017 Q3 | 96.94 Million CNY | 3.37% |
| 2016 Q1 | 70.65 Million CNY | -13.41% |
| 2016 Q2 | 78.59 Million CNY | 11.23% |
| 2016 Q4 | 107.21 Million CNY | -8.0% |
| 2016 FY | 373 Million CNY | 106.02% |
| 2016 Q3 | 116.54 Million CNY | 48.29% |
| 2015 Q4 | 81.59 Million CNY | 52.87% |
| 2015 FY | 181.05 Million CNY | 299.41% |
| 2015 Q3 | 53.37 Million CNY | 82.98% |
| 2015 Q2 | 29.17 Million CNY | 72.47% |
| 2015 Q1 | 16.91 Million CNY | 60.42% |
| 2014 FY | 45.33 Million CNY | -24.3% |
| 2014 Q4 | 10.54 Million CNY | 138.85% |
| 2014 Q3 | 4.41 Million CNY | -80.6% |
| 2014 Q2 | 22.75 Million CNY | 198.62% |
| 2014 Q1 | 7.61 Million CNY | -24.96% |
| 2013 FY | 59.87 Million CNY | 340.48% |
| 2013 Q4 | 10.15 Million CNY | -61.23% |
| 2013 Q3 | 26.19 Million CNY | 167.8% |
| 2013 Q2 | 9.78 Million CNY | -28.85% |
| 2013 Q1 | 13.74 Million CNY | 360.92% |
| 2012 FY | 13.59 Million CNY | -85.52% |
| 2012 Q1 | 10.14 Million CNY | 18.29% |
| 2012 Q3 | 833.58 Thousand CNY | -89.43% |
| 2012 Q2 | 7.88 Million CNY | -22.24% |
| 2012 Q4 | -5.26 Million CNY | -732.1% |
| 2011 Q2 | 32.52 Million CNY | 26.61% |
| 2011 Q1 | 25.68 Million CNY | 40.18% |
| 2011 FY | 93.89 Million CNY | -0.87% |
| 2011 Q4 | 8.57 Million CNY | -68.36% |
| 2011 Q3 | 27.09 Million CNY | -16.69% |
| 2010 Q3 | 13.71 Million CNY | -64.6% |
| 2010 Q4 | 18.32 Million CNY | 33.64% |
| 2010 FY | 94.71 Million CNY | 0.39% |
| 2010 Q1 | 23.93 Million CNY | 9.04% |
| 2010 Q2 | 38.73 Million CNY | 61.85% |
| 2009 Q2 | 21.67 Million CNY | 37.8% |
| 2009 Q4 | 21.95 Million CNY | -37.26% |
| 2009 FY | 94.34 Million CNY | -59.09% |
| 2009 Q3 | 34.98 Million CNY | 61.41% |
| 2009 Q1 | 15.73 Million CNY | -18.58% |
| 2008 FY | 230.6 Million CNY | -49.54% |
| 2008 Q4 | 19.32 Million CNY | -52.74% |
| 2008 Q3 | 40.88 Million CNY | -40.49% |
| 2008 Q2 | 68.7 Million CNY | -32.44% |
| 2008 Q1 | 101.69 Million CNY | -44.93% |
| 2007 Q3 | 169 Million CNY | 166.24% |
| 2007 Q4 | 184.67 Million CNY | 9.27% |
| 2007 Q2 | 63.47 Million CNY | 59.33% |
| 2007 Q1 | 39.84 Million CNY | 15.04% |
| 2007 FY | 456.99 Million CNY | 289.99% |
| 2006 Q1 | 24.22 Million CNY | -20.89% |
| 2006 Q2 | 28.51 Million CNY | 17.72% |
| 2006 Q3 | 29.8 Million CNY | 4.5% |
| 2006 Q4 | 34.63 Million CNY | 16.2% |
| 2006 FY | 117.18 Million CNY | 37.93% |
| 2005 FY | 84.95 Million CNY | 25.8% |
| 2005 Q2 | 15.21 Million CNY | -13.96% |
| 2005 Q4 | 30.62 Million CNY | 42.9% |
| 2005 Q1 | 17.68 Million CNY | -27.85% |
| 2005 Q3 | 21.43 Million CNY | 40.83% |
| 2004 FY | 67.53 Million CNY | -7.85% |
| 2004 Q4 | 24.51 Million CNY | 76.55% |
| 2004 Q3 | 13.88 Million CNY | -7.27% |
| 2004 Q1 | 14.16 Million CNY | -21.46% |
| 2004 Q2 | 14.97 Million CNY | 5.73% |
| 2003 Q4 | 18.03 Million CNY | 19.65% |
| 2003 Q2 | 19.1 Million CNY | -9.41% |
| 2003 FY | 73.28 Million CNY | -2.11% |
| 2003 Q1 | 21.08 Million CNY | 10.6% |
| 2003 Q3 | 15.06 Million CNY | -21.11% |
| 2002 Q1 | 40.83 Million CNY | 0.0% |
| 2002 Q4 | 19.06 Million CNY | 4.94% |
| 2002 Q3 | 18.16 Million CNY | -69.4% |
| 2002 Q2 | 59.36 Million CNY | 45.41% |
| 2002 FY | 74.86 Million CNY | -7.15% |
| 2001 FY | 80.62 Million CNY | 23.3% |
| 2000 FY | 65.39 Million CNY | -16.57% |
| 1999 FY | 78.38 Million CNY | 8.87% |
| 1998 FY | 71.99 Million CNY | 2.61% |
| 1997 FY | 70.15 Million CNY | 51.47% |
| 1996 FY | 46.31 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 2.18 Billion CNY | 91.418% |
| Zhejiang Zhenyuan Share Co., Ltd. | 762.64 Million CNY | 75.358% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 458.96 Million CNY | 59.053% |
| Yifan Pharmaceutical Co., Ltd. | 1.83 Billion CNY | 89.735% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 347.72 Million CNY | 45.952% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 10.7 Billion CNY | 98.244% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 620.91 Million CNY | 69.733% |
| Boai NKY Medical Holdings Ltd. | 894.38 Million CNY | 78.987% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 808 Million CNY | 76.741% |